BLK · News · 20261021N

Institutional Ownership Changes

BlackRock, Inc. · 2026-10-21 · Importance 13 · Surprise 24

BlackRock reduced its voting rights in ChemoMetec A/S to 14.97% on October 15, 2026, falling below Denmark’s 15% disclosure threshold. It increased voting rights through financial instruments to 0.11%, leaving its aggregate position unchanged at 15.08%. BlackRock also reported total voting rights of 9.26% in Symrise AG, comprising 8.82% in direct and attributed voting rights and 0.44% through instruments.

Key facts

• On 15 October 2026 BlackRock reduced its voting rights attached to shares in ChemoMetec A/S to 14.97%, falling below the 15% threshold under the Danish Capital Markets Act. source
• BlackRock announced total voting rights in Symrise AG of 9.26%, combining 8.82% in direct and attributed voting rights and 0.44% in instruments, crossing a threshold on October 15, 2026. source
• BlackRock increased its position in voting rights attached to financial instruments in ChemoMetec A/S to 0.11%, so the aggregate position remained 15.08%. source
• BlackRock's position in ChemoMetec A/S at that time was: voting rights attached to shares 14.97%, voting rights through financial instruments 0.11%, total 15.08%. source
• BlackRock adjusted its stake in Brazilian utility Equatorial SA. source